Biotronik SE & Co KG - Product Pipeline Analysis, 2024 Update
Summary
Biotronik SE & Co KG (Biotronik) is a medical device company that develops, manufactures, and distributes cardiovascular and endovascular solutions. The company’s cardiac rhythm management solutions include implantable devices, leads, and accessories and external devices to treat and manage arrhythmia-related diseases. Its electrophysiology products include heart catheters used to diagnose and treat cardiac arrhythmias; and vascular intervention products such as stent systems, balloon catheters, and guide wires for the treatment of peripheral, and coronary artery diseases. Biotronik has manufacturing facilities in Germany, Singapore, Switzerland, and the US. Biotronik is headquartered in Berlin, Germany.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
The report analyzes all pipeline products in development for the company Biotronik SE & Co KG
The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
The report provides detailed description of products in development, technical specification and functions
The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
To formulate effective Research & Development strategies
Develop market-entry and market expansion strategies
Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Biotronik SE & Co KG Company Overview
Biotronik SE & Co KG Company Snapshot
Biotronik SE & Co KG Pipeline Products and Ongoing Clinical Trials Overview
Biotronik SE & Co KG – Pipeline Analysis Overview
Business Description
Biotronik SE & Co KG - Key Facts
Biotronik SE & Co KG - Major Products and Services
Biotronik SE & Co KG Pipeline Products by Development Stage
Biotronik SE & Co KG Ongoing Clinical Trials by Trial Status
Biotronik SE & Co KG Pipeline Products Overview
AI Based Telemedicine - Myocardial Infarction
AI Based Telemedicine - Myocardial Infarction Product Overview
Table 20: Cardiac Conduction System - Product Status
Table 21: Cardiac Conduction System - Product Description
Table 22: Coronary Stent System - Product Status
Table 23: Coronary Stent System - Product Description
Table 24: Delivr - Product Status
Table 25: Delivr - Product Description
Table 26: DREAMS 3G System - Product Status
Table 27: DREAMS 3G System - Product Description
Table 28: DREAMS 3G System - BIOTRONIK - Safety and Clinical Performance of the - Sirolimus-Eluting Resorbable Coronary Magnesium Scaffold System (DREAMS 3G) in the Treatment of Subjects with de Novo Lesions in Native Coronary Arteries
Table 29: DREAMS 3G System - BIOTRONIK-Safety and Clinical Performance of the Drug Eluting Resorbable Coronary MAGnesium Scaffold System (DREAMS 3G) in the Treatment of Subjects With de Novo Lesions in Native Coronary Arteries: BIOMAG-II: A Randomized Controlled Trial
Table 30: ElePulse System - Product Status
Table 31: ElePulse System - Product Description
Table 32: ElePulse System - Rapid One-Shot Electroporation Trial For Atrial Fibrillation: Reset-AF: Investigating the Effect of A Novel Intervention on Atrial Fibrillation Recurrence
Table 33: Freesolve BTK RMS - Product Status
Table 34: Freesolve BTK RMS - Product Description
Table 35: Hatriq - Product Status
Table 36: Hatriq - Product Description
Table 37: Implantable Pressure Sensor - Product Status
Table 41: Magmaris Bioresorbable Magnesium Scaffold - Biotroniks - Safety and Performance in de Novo Lesion of Native Coronary Arteries with Magmaris- Registry: BIOSOLVE-IV
Table 42: Magmaris Bioresorbable Magnesium Scaffold - Retrospective, Observational Register to Investigate the Procedural and Post Procedural Implantation of Bioabsorbable Magnesium Scaffolds Magmaris (MAGIC Registry)